These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31214622)

  • 1. Sjogren's Syndrome and TAM Receptors: A Possible Contribution to Disease Onset.
    Witas R; Peck AB; Ambrus JL; Nguyen CQ
    J Immunol Res; 2019; 2019():4813795. PubMed ID: 31214622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of Tyro3/Axl/Mer signaling with inflammatory response, disease activity in patients with primary Sjögren's syndrome.
    Qin B; Wang J; Ma N; Yang M; Fu H; Liang Y; Huang F; Yang Z; Zhong R
    Joint Bone Spine; 2015 Jul; 82(4):258-63. PubMed ID: 25881761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective Efferocytosis in a Murine Model of Sjögren's Syndrome Is Mediated by Dysfunctional Mer Tyrosine Kinase Receptor.
    Witas R; Rasmussen A; Scofield RH; Radfar L; Stone DU; Grundahl K; Lewis D; Sivils KL; Lessard CJ; Farris AD; Nguyen CQ
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer.
    Zagórska A; Través PG; Jiménez-García L; Strickland JD; Oh J; Tapia FJ; Mayoral R; Burrola P; Copple BL; Lemke G
    Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32571802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
    Peck AB; Nguyen CQ; Ambrus J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome.
    Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML
    J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo signaling pathway is required for salivary gland development and its dysregulation is associated with Sjogren's syndrome.
    Enger TB; Samad-Zadeh A; Bouchie MP; Skarstein K; Galtung HK; Mera T; Walker J; Menko AS; Varelas X; Faustman DL; Jensen JL; Kukuruzinska MA
    Lab Invest; 2013 Nov; 93(11):1203-18. PubMed ID: 24080911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells.
    Park HJ; Baen JY; Lee YJ; Choi YH; Kang JL
    Mol Biol Cell; 2012 Aug; 23(16):3254-65. PubMed ID: 22740630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR7 Signaling Drives the Development of Sjögren's Syndrome.
    Wang Y; Roussel-Queval A; Chasson L; Hanna Kazazian N; Marcadet L; Nezos A; Sieweke MH; Mavragani C; Alexopoulou L
    Front Immunol; 2021; 12():676010. PubMed ID: 34108972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation.
    Sandahl M; Hunter DM; Strunk KE; Earp HS; Cook RS
    BMC Dev Biol; 2010 Dec; 10():122. PubMed ID: 21192804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers.
    Grabiec AM; Goenka A; Fife ME; Fujimori T; Hussell T
    Eur J Immunol; 2018 May; 48(5):855-860. PubMed ID: 29400409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual role for interferon-gamma in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse.
    Cha S; Brayer J; Gao J; Brown V; Killedar S; Yasunari U; Peck AB
    Scand J Immunol; 2004 Dec; 60(6):552-65. PubMed ID: 15584966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.
    Hauk V; Calafat M; Larocca L; Fraccaroli L; Grasso E; Ramhorst R; Leirós CP
    Clin Exp Immunol; 2011 Dec; 166(3):309-16. PubMed ID: 22059987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of autophagy impairment inhibits pathology in the NOD.H-2h4 mouse model of primary Sjögren's syndrome.
    Voynova E; Lefebvre F; Qadri A; Muller S
    J Autoimmun; 2020 Mar; 108():102418. PubMed ID: 32029330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
    Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
    Elife; 2014 Sep; 3():. PubMed ID: 25265470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment.
    Myers KV; Amend SR; Pienta KJ
    Mol Cancer; 2019 May; 18(1):94. PubMed ID: 31088471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus.
    Ballantine L; Midgley A; Harris D; Richards E; Burgess S; Beresford MW
    Pediatr Rheumatol Online J; 2015; 13():10. PubMed ID: 25878564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAM receptors and their ligand-mediated activation: Role in atherosclerosis.
    Cai B; Kasikara C
    Int Rev Cell Mol Biol; 2020; 357():21-33. PubMed ID: 33234243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAM receptors in cardiovascular disease.
    McShane L; Tabas I; Lemke G; Kurowska-Stolarska M; Maffia P
    Cardiovasc Res; 2019 Jul; 115(8):1286-1295. PubMed ID: 30980657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A MZB Cell Activation Profile Present in the Lacrimal Glands of Sjögren's Syndrome-Susceptible C57BL/6.NOD-
    Peck AB; Nguyen CQ; Ambrus JL
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.